Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1Advanced Breast Cancer 1

Interventions

Tamoxifen 7Specimen Handling 7exemestane 3Letrozole 3Anastrozole 3Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Biopsy 2ruxolitinib 1poly ICLC 1fezolinetant 1elacestrant 1Testosterone 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Selective Estrogen Receptor Modulators 1Radiotherapy 1Radiation 1Protons 1Proton Therapy 1Omacor 1Neoadjuvant Therapy 1Multicenter Studies as Topic 1Metformin 1Medicare 1Mastectomy, Segmental 1Mastectomy 1Magnetic Resonance Spectroscopy 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Intraductal, Noninfiltrating × Selective Estrogen Receptor Modulators × 90 days × Clear all
NCT06218303 2026-03-12

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

University of Pittsburgh

Phase 1 Recruiting
50 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡